Neovasc to Present at the Piper Jaffray 29th Annual Healthcare Conference
28 November 2017 - 2:27AM
PR Newswire (Canada)
NASDAQ, TSX: NVCN
VANCOUVER, Nov. 27, 2017 /CNW/ - Neovasc Inc.
("Neovasc" or the "Company") (NASDAQ: NVCN) (TSX:
NVC) today announced that Chris
Clark, chief financial officer, is scheduled to present at
the 29th Annual Piper Jaffray Healthcare Conference on
Wednesday, November 29th
at 7:50 am ET at the Lotte New York
Palace in New York City.
A live audio webcast of the presentation will be available on
the Investors page of Neovasc's website at www.neovasc.com.
About Neovasc Inc.
Neovasc is a specialty medical device company that develops,
manufactures and markets products for the rapidly growing
cardiovascular marketplace. Its products include the Neovasc
Reducer™, for the treatment of refractory angina which is not
currently available in the United
States and has been available in Europe since 2015 and the Tiara™, for the
transcatheter treatment of mitral valve disease, which is currently
under investigation in the United
States, Canada and
Europe. The Company also sells a
line of advanced biological tissue products that are used as key
components in third-party medical products including transcatheter
heart valves. For more information, visit: www.neovasc.com.
SOURCE Neovasc Inc.
Copyright 2017 Canada NewsWire
Neovasc (NASDAQ:NVCN)
Historical Stock Chart
From Sep 2024 to Oct 2024
Neovasc (NASDAQ:NVCN)
Historical Stock Chart
From Oct 2023 to Oct 2024
Real-Time news about Neovasc Inc (NASDAQ): 0 recent articles
More Neovasc Inc. News Articles